Finance
Markets
No recent trading data. The last price we hold for ELV is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

ELV

stock Healthcare Healthcare Plans
Elevance Health
$391.27 +2.24 (+0.58%) Delayed · quoted 46d ago
Mixed 54% Steady

What the indicators say

Bullish 5 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
58
0oversold 30overbought 70100

RSI 58 — firm momentum, not yet overbought.

EMA 21 $385.11
Above
Near-term trend is up
SMA 50 $351.04
Above
Medium-term trend is up
SMA 200 $336.13
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $367.93
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $390.29 High $396.75
Open
$391.39
+0.61%
Close
$391.39
+0.61%
52-week range where the price sits across its year
52w low $273.71 52w high $408.00
Current
$391.39
Prev close
$389.03
Volume 0.43× the 3-month average
0 avg 2× avg
Today
797.14K
3-mo avg
1.86M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2290 days ago
Next expected
Jul 165 days ago

Recent earnings dates

  • Apr 22 90 days ago
  • Jan 28 174 days ago
  • Oct 21, 2025 273 days ago
  • Jul 17, 2025 369 days ago

Past earnings dates come from ELV’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), ELV’s fundamentals read as fair overall.

P/E ratio Strong
16.6x

At 16.6x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
2.8%

A 2.8% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
12.9%

A 12.9% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
4.7%

A 4.7% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.77

At 1.77, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.54

At 1.54, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+12.5%

Revenue grew 12.5% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-5.3%

Net income fell 5.3% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $138.6B$156.6B$171.3B$177.0B$199.1B
Net income $6.2B$5.9B$6.0B$6.0B$5.7B
Diluted EPS $24.95$24.28$25.22$25.68$25.21
Dividend / share $4.52$5.12$5.92——
Total assets $97.5B$102.8B$108.9B$116.9B$121.5B
Total liabilities $61.3B$66.4B$69.5B$75.5B$77.5B
Shareholder equity $36.1B$36.3B$39.4B$41.3B$43.9B

Leadershipsynced from SEC 57d ago

  • Penczek Ronald W CAO & Controller
  • Devore Susan D. Director
  • Dixon Robert L Jr Director
  • Hay Lewis Iii Director
  • Jallal Bahija Director
  • Neri Antonio F Director
  • Peru Ramiro G Director
  • Schneider Ryan M. Director
  • Schulman Amy W Director
  • Strable-Soethout Deanna D Director

Officers and board are drawn from ELV’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Fair
2025 total
$6.84
2026 so far
$1.721 payment
2026 projected
$6.88+0.6% vs 2025

Projection scales ELV’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 10 $1.72
  • Dec 5, 2025 $1.71
  • Sep 10, 2025 $1.71
  • Jun 10, 2025 $1.71
  • Mar 10, 2025 $1.71
  • Dec 5, 2024 $1.63
  • Sep 10, 2024 $1.63
  • Jun 10, 2024 $1.63
  • Mar 7, 2024 $1.63
  • Dec 5, 2023 $1.48
  • Sep 7, 2023 $1.48
  • Jun 8, 2023 $1.48
  • Mar 9, 2023 $1.48
  • Dec 2, 2022 $1.28
  • Sep 8, 2022 $1.28
  • Jun 9, 2022 $1.28
  • Mar 9, 2022 $1.28
  • Dec 2, 2021 $1.13
  • Sep 9, 2021 $1.13
  • Jun 9, 2021 $1.13

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved